Quantcast

Latest Biothorpe Pharmaceuticals Stories

2008-09-25 09:00:16

US-based biotechnology company ZaBeCor Pharmaceuticals has announced the formation of its new subsidiary Biothorpe Pharmaceuticals, a biotechnology company focused on the development of siRNA, antisense and other molecular technologies for the treatment of cancer. Biothorpe's intellectual property portfolio includes the therapeutic use of siRNA and other oligonucleotides directed at Syk kinase. Biothorpe intends to license its intellectual property for the treatment of three cancers - acute...

2008-09-24 09:00:13

ZaBeCor Pharmaceuticals ("ZaBeCor") announces today the formation of its new subsidiary Biothorpe Pharmaceuticals ("Biothorpe" or the "Company"), a biotechnology company focused on the development of siRNA, antisense and other molecular technologies for the treatment of cancer. Recent studies in academia and in the biopharmaceutical industry indicate that Syk kinase is required for the proliferation of malignant cells in several cancers. Biothorpe's intellectual property portfolio includes...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related